Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025
Haemonetics (NYSE: HAE) has scheduled the release of its first quarter fiscal year 2026 financial results for August 7, 2025 at 6:00 am ET. The company will host a conference call with investors and analysts at 8:00 am ET on the same day to discuss the results and take questions.
Participants can access the call via teleconference after completing registration, and are encouraged to join 10 minutes before the start. A live webcast will be available on Haemonetics' investor relations website, with a replay accessible for one year starting August 7, 2025, at 11:00 am ET.
Haemonetics (NYSE: HAE) ha programmato la pubblicazione dei risultati finanziari del primo trimestre dell'anno fiscale 2026 per il 7 agosto 2025 alle ore 6:00 ET. La società terrà una conference call con investitori e analisti alle 8:00 ET dello stesso giorno per discutere i risultati e rispondere alle domande.
I partecipanti potranno accedere alla chiamata tramite teleconferenza dopo aver completato la registrazione e sono invitati a collegarsi 10 minuti prima dell'inizio. Una diretta web sarà disponibile sul sito delle relazioni con gli investitori di Haemonetics, con una replica accessibile per un anno a partire dal 7 agosto 2025 alle 11:00 ET.
Haemonetics (NYSE: HAE) ha programado la publicación de sus resultados financieros del primer trimestre del año fiscal 2026 para el 7 de agosto de 2025 a las 6:00 am ET. La compañía realizará una conferencia telefónica con inversores y analistas a las 8:00 am ET del mismo día para discutir los resultados y responder preguntas.
Los participantes podrán acceder a la llamada por teleconferencia tras completar el registro y se recomienda conectarse 10 minutos antes del inicio. Habrá una transmisión en vivo disponible en la página de relaciones con inversores de Haemonetics, con una repetición accesible durante un año desde el 7 de agosto de 2025 a las 11:00 am ET.
Haemonetics (NYSE: HAE)는 2026 회계연도 1분기 재무 결과를 2025년 8월 7일 오전 6시(동부시간)에 발표할 예정입니다. 회사는 같은 날 오전 8시(동부시간)에 투자자 및 애널리스트와의 컨퍼런스 콜을 개최하여 결과를 논의하고 질의응답을 진행합니다.
참가자는 등록을 완료한 후 전화 회의에 참여할 수 있으며 시작 10분 전까지 접속할 것을 권장합니다. Haemonetics 투자자 관계 웹사이트에서 생중계가 제공되며, 2025년 8월 7일 오전 11시(동부시간)부터 1년간 다시보기 서비스를 이용할 수 있습니다.
Haemonetics (NYSE : HAE) a programmé la publication de ses résultats financiers du premier trimestre de l'exercice 2026 pour le 7 août 2025 à 6h00 ET. La société organisera une conférence téléphonique avec les investisseurs et les analystes à 8h00 ET le même jour pour discuter des résultats et répondre aux questions.
Les participants pourront accéder à l'appel par téléconférence après avoir complété leur inscription et sont invités à se connecter 10 minutes avant le début. Une diffusion en direct sera disponible sur le site des relations investisseurs de Haemonetics, avec un replay accessible pendant un an à partir du 7 août 2025 à 11h00 ET.
Haemonetics (NYSE: HAE) hat die Veröffentlichung der Finanzergebnisse für das erste Quartal des Geschäftsjahres 2026 für den 7. August 2025 um 6:00 Uhr ET geplant. Das Unternehmen wird am selben Tag um 8:00 Uhr ET eine Telefonkonferenz mit Investoren und Analysten abhalten, um die Ergebnisse zu besprechen und Fragen zu beantworten.
Teilnehmer können nach Registrierung per Telefonkonferenz teilnehmen und werden gebeten, sich 10 Minuten vor Beginn einzuwählen. Ein Live-Webcast wird auf der Investor-Relations-Webseite von Haemonetics verfügbar sein, mit einer Wiedergabe, die ab dem 7. August 2025 um 11:00 Uhr ET ein Jahr lang abrufbar ist.
- None.
- None.
The call can be accessed via teleconference at: Q1 2026 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/wv7zkgdh
A replay of the conference call and webcast will be available for one year beginning on August 7, 2025 at 11:00 am ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com
David Trenk, Manager-Investor Relations
(203) 733-4987
david.trenk@haemonetics.com
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-first-quarter-fiscal-year-2026-results-august-7-2025-302501499.html
SOURCE Haemonetics Corporation
FAQ
When will Haemonetics (HAE) release Q1 2026 earnings?
How can investors join the Haemonetics Q1 2026 earnings call?
Will there be a replay available for Haemonetics' Q1 2026 earnings call?
What time should participants join the Haemonetics earnings call?
